The Chicago Life Science Consortium (CLSC) announces the formation of a partnership with the Wuhan Biolake in Wuhan City, Hubei Province, China. The partnership revolves around the provision of the Consortium’s first international office space in the Wuhan Biopharma Park. Wuhan Biolake has donated office space at its multi-sector science and technology park. The addition of a second CLSC office (the home office being in the US) represents a significant step forward for the young Chicago Life Science Consortium. This step moves the CLSC toward its goal of becoming one of the world’s leading regional incubators and accelerators for early and middle stage companies within the healthcare and life sciences sectors. This strategic arrangement presents opportunities for the two organizations to partner in ways that benefit life science organizations, biopharma entrepreneurs, and local economies in both Chicago and Wuhan.
- Horizon Pharma Announces the Appointment of H. Thomas Watkins to Its Board ... - MENAFN.COM April 17, 2014Horizon Pharma Announces the Appointment of H. Thomas Watkins to Its Board ...MENAFN.COMDEERFIELD, IL, Apr 17, 2014 (Menafn - Marketwired via COMTEX) --Horizon Pharma, Inc. HZNP today announced the appointmentof H. Thomas Watkins, former director, president and chief executiveofficer of Human Genome Sciences, to its board of directors ...and more »